These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16740781)

  • 1. TC1(C8orf4) correlates with Wnt/beta-catenin target genes and aggressive biological behavior in gastric cancer.
    Kim B; Koo H; Yang S; Bang S; Jung Y; Kim Y; Kim J; Park J; Moon RT; Song K; Lee I
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3541-8. PubMed ID: 16740781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TC1 (C8orf4) enhances the Wnt/beta-catenin pathway by relieving antagonistic activity of Chibby.
    Jung Y; Bang S; Choi K; Kim E; Kim Y; Kim J; Park J; Koo H; Moon RT; Song K; Lee I
    Cancer Res; 2006 Jan; 66(2):723-8. PubMed ID: 16424001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TC-1 (c8orf4) enhances aggressive biologic behavior in lung cancer through the Wnt/β-catenin pathway.
    Su K; Huang L; Li W; Yan X; Li X; Zhang Z; Jin F; Lei J; Ba G; Liu B; Wang X; Wang Y
    J Surg Res; 2013 Nov; 185(1):255-63. PubMed ID: 23880650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The high expression of TC1 (C8orf4) was correlated with the expression of β-catenin and cyclin D1 and the progression of squamous cell carcinomas of the tongue.
    Zhang P; Cao HY; Bai LL; Li WN; Wang Y; Chen SY; Zhang L; Yang LH; Xu HT; Wang EH
    Tumour Biol; 2015 Sep; 36(9):7061-7. PubMed ID: 25869879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
    Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
    Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
    Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
    Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/β-catenin signaling.
    Qiu HB; Zhang LY; Ren C; Zeng ZL; Wu WJ; Luo HY; Zhou ZW; Xu RH
    PLoS One; 2013; 8(3):e56959. PubMed ID: 23554857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LDLRAD2 overexpression predicts poor prognosis and promotes metastasis by activating Wnt/β-catenin/EMT signaling cascade in gastric cancer.
    Wei Y; Zhang F; Zhang T; Zhang Y; Chen H; Wang F; Li Y
    Aging (Albany NY); 2019 Oct; 11(20):8951-8968. PubMed ID: 31649207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt pathway is involved in advanced gastric carcinoma.
    Zhang H; Xue Y
    Hepatogastroenterology; 2008; 55(84):1126-30. PubMed ID: 18705344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PYGB Promoted Tumor Progression by Regulating Wnt/β-Catenin Pathway in Gastric Cancer.
    Xia B; Zhang K; Liu C
    Technol Cancer Res Treat; 2020; 19():1533033820926592. PubMed ID: 32462986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway.
    Lu Q; Ma X; Li Y; Song W; Zhang L; Shu Y; Wan B
    J Cell Biochem; 2019 Mar; 120(3):2897-2907. PubMed ID: 30500980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEF2D/Wnt/β-catenin pathway regulates the proliferation of gastric cancer cells and is regulated by microRNA-19.
    Xu K; Zhao YC
    Tumour Biol; 2016 Jul; 37(7):9059-69. PubMed ID: 26762410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer.
    Lowy AM; Clements WM; Bishop J; Kong L; Bonney T; Sisco K; Aronow B; Fenoglio-Preiser C; Groden J
    Cancer Res; 2006 May; 66(9):4734-41. PubMed ID: 16651426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHD8 is an independent prognostic indicator that regulates Wnt/β-catenin signaling and the cell cycle in gastric cancer.
    Sawada G; Ueo H; Matsumura T; Uchi R; Ishibashi M; Mima K; Kurashige J; Takahashi Y; Akiyoshi S; Sudo T; Sugimachi K; Doki Y; Mori M; Mimori K
    Oncol Rep; 2013 Sep; 30(3):1137-42. PubMed ID: 23835524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells.
    Yamamoto H; Kitadai Y; Yamamoto H; Oue N; Ohdan H; Yasui W; Kikuchi A
    Gastroenterology; 2009 Jul; 137(1):242-52, 252.e1-6. PubMed ID: 19582886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zic1 suppresses gastric cancer metastasis by regulating Wnt/β-catenin signaling and epithelial-mesenchymal transition.
    Ge Q; Hu Y; He J; Chen F; Wu L; Tu X; Qi Y; Zhang Z; Xue M; Chen S; Zhong J; Wang L
    FASEB J; 2020 Feb; 34(2):2161-2172. PubMed ID: 31909528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSulf-1 inhibits cell proliferation and invasion in human gastric cancer.
    Li J; Mo ML; Chen Z; Yang J; Li QS; Wang DJ; Zhang H; Ye YJ; Li HL; Zhang F; Zhou HM
    Cancer Sci; 2011 Oct; 102(10):1815-21. PubMed ID: 21722266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid cancer 1 (C8orf4) shows high expression, no mutation and reduced methylation level in lung cancers, and its expression correlates with β-catenin and DNMT1 expression and poor prognosis.
    Zheng YW; Zhang L; Wang Y; Chen SY; Lei L; Tang N; Yang DL; Bai LL; Zhang XP; Jiang GY; Yang LH; Xu HT; Li QC; Qiu XS; Wang EH
    Oncotarget; 2017 Sep; 8(38):62880-62890. PubMed ID: 28968956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling.
    Fang F; Zhao WY; Li RK; Yang XM; Li J; Ao JP; Jiang SH; Kong FZ; Tu L; Zhuang C; Qin WX; He P; Zhang WM; Cao H; Zhang ZG
    Int J Clin Exp Pathol; 2014; 7(10):6447-61. PubMed ID: 25400723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.